Phosplatin Therapeutics saddened by the loss of Rathindra Bose, inventor of phosphaplatins

Previous
Previous

Phosplatin Therapeutics Announces the Execution of Regional Licensing Agreement for its Novel Therapeutic Agent in Oncology, PT-112

Next
Next

Phosplatin Therapeutics Appoints José Jimeno, M.D., PhD as Chief Medical Officer